QIAGEN N.V. has announced a broad agreement with Ares Genetics, a subsidiary of Curetis N.V., to develop innovative bioi...
A genetic variant found only in people of African descent significantly increases a smoker’s preference for cigare...
Saniona, a biotech company focused on CNS and eating disorders has announced the successful completion of preclinical de...
Europe healthcare artificial intelligence market witnessed 41.8% growth throughout the analysis period. Adoption of...
Ahead of World Hearing Day (3 March), the World Health Organization (WHO) and the International Telecommunication Union ...
Quest Diagnostics, the world's leading provider of diagnostic information services has announced that Gabrielle Wolfson,...
Tandem Diabetes Care has announced the U.S. Food and Drug Administration (FDA) approval of its t:slim X2™ insulin ...
Safe Medical Design, Inc. (SMD), a medical device company dedicated to developing safe and cost-effective solutions in u...
Navitas Life Sciences, a TAKE Solutions Enterprise has announced that it will be acquiring Life Sciences services player...
The Janssen Pharmaceutical Companies of Johnson & Johnson has announced that the U.S. Food and Drug Administration (...
Haselmeier is a leading solution provider for self-injection devices. As an innovative and strategic partner for ph...
Harvard engineers and stem cell biologists have developed an injectable sponge-like gel that enhances the production T-c...
Boehringer Ingelheim (Canada) Ltd. and IBM Canada have announced at the Healthcare Information and Management Systems So...
Samsung Electronics America is showcasing its latest technology innovations that help healthcare providers offer value-b...
With the mutual goal of improving access to life-saving vaccines, the Bill & Melinda Gates Foundation recommitted it...
Pfizer Inc. and Astellas Pharma Inc. have announced the results from the Phase 3 ARCHES trial in men with metastatic hor...
Merck and Pfizer Inc. has announced that the US Food and Drug Administration (FDA) has accepted for Priority Review...
An antibody-based treatment can gently and effectively eliminate diseased blood-forming stem cells in the bone marrow to...
